I think your assertion is entirely false. The FDA must be unbiased in their decision making around AA / NDA approvals. They would seem patently biased if they did not hold SRPT to the same regulatory standards that GSK was held to, even if SRPT's drug had fewer side effects. Approval will happen, it will just take longer than the super bulls were hoping for. Don't paint me with a bears brush. I'm long and will remain so. Disappointed? Yes, without question. But, these roads are almost always bumpy.